Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C14H18F3NO.ClH |
| Molecular Weight | 309.755 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC(C)N1CCOC(C1)C2=CC=CC(=C2)C(F)(F)F
InChI
InChIKey=XYYSVSLSSDHEGA-UHFFFAOYSA-N
InChI=1S/C14H18F3NO.ClH/c1-10(2)18-6-7-19-13(9-18)11-4-3-5-12(8-11)14(15,16)17;/h3-5,8,10,13H,6-7,9H2,1-2H3;1H
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C14H18F3NO |
| Molecular Weight | 273.294 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Oxaflozane is non-tricyclic antidepressant with serotoninergic action. In animals, oxaflozane has anti-cataleptic and anti-aggressive action with weak potentiation of stereotypes provoked by amphetamine. Oxaflozane was developed by Solvay Pharma and marketed in France under tradename Conflictan. The drug was discontinued in 2004.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 20:06:11 GMT 2025
by
admin
on
Mon Mar 31 20:06:11 GMT 2025
|
| Record UNII |
E10FW59D1I
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
247-854-2
Created by
admin on Mon Mar 31 20:06:11 GMT 2025 , Edited by admin on Mon Mar 31 20:06:11 GMT 2025
|
PRIMARY | |||
|
315281
Created by
admin on Mon Mar 31 20:06:11 GMT 2025 , Edited by admin on Mon Mar 31 20:06:11 GMT 2025
|
PRIMARY | |||
|
m861
Created by
admin on Mon Mar 31 20:06:11 GMT 2025 , Edited by admin on Mon Mar 31 20:06:11 GMT 2025
|
PRIMARY | Merck Index | ||
|
E10FW59D1I
Created by
admin on Mon Mar 31 20:06:11 GMT 2025 , Edited by admin on Mon Mar 31 20:06:11 GMT 2025
|
PRIMARY | |||
|
100000085504
Created by
admin on Mon Mar 31 20:06:11 GMT 2025 , Edited by admin on Mon Mar 31 20:06:11 GMT 2025
|
PRIMARY | |||
|
26629-86-7
Created by
admin on Mon Mar 31 20:06:11 GMT 2025 , Edited by admin on Mon Mar 31 20:06:11 GMT 2025
|
PRIMARY | |||
|
SUB03560MIG
Created by
admin on Mon Mar 31 20:06:11 GMT 2025 , Edited by admin on Mon Mar 31 20:06:11 GMT 2025
|
PRIMARY | |||
|
C005357
Created by
admin on Mon Mar 31 20:06:11 GMT 2025 , Edited by admin on Mon Mar 31 20:06:11 GMT 2025
|
PRIMARY | |||
|
21124624
Created by
admin on Mon Mar 31 20:06:11 GMT 2025 , Edited by admin on Mon Mar 31 20:06:11 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE | |||
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |